Glimepiride 1mg + Metformin 500mg (Bi-Layer Tablet, SR) is a combination oral antidiabetic medication designed to manage type 2 diabetes mellitus. The dual-action formulation combines Glimepiride, a sulfonylurea that stimulates insulin secretion from pancreatic beta cells, with Metformin, a biguanide that reduces hepatic glucose production and enhances insulin sensitivity. The bi-layer sustained-release (SR) tablet ensures controlled release of Metformin for prolonged glucose regulation, while Glimepiride acts promptly to lower blood sugar levels. This combination offers an effective and convenient approach for maintaining optimal glycemic control, reducing HbA1c levels, and minimizing the risk of postprandial hyperglycemia.
